Human Brain Gene Expression Linked to Cognition & Behavior | Molecular Psychiatry

Researchers have pinpointed a distinct and reproducible gene expression program linked to neurotransmission within the living human brain, a finding that offers an unprecedented look at the molecular underpinnings of cognition, emotion and behavior. The study, published in Molecular Psychiatry, represents a significant step forward in understanding how genes contribute to brain function in real-time, rather than relying on post-mortem tissue analysis.

Decoding the Language of Brain Cells

Neurotransmission, at its core, is the process by which neurons communicate with each other using electrical and chemical signals. This intricate communication is fundamental to everything we think, feel, and do. But the precise genetic mechanisms orchestrating this process in a living human brain have remained largely elusive – until now. The research team, based at Mount Sinai, characterized gene expression in 130 prefrontal cortex (PFC) samples obtained from participants of the Living Brain Project (LBP) during neurosurgical procedures. The study details how these samples were collected during procedures where intracranial recordings of neurotransmission traits were as well being conducted in deep brain structures.

Gene expression refers to the process by which information from a gene is used in the synthesis of a functional gene product – essentially, how genes are “turned on” or “turned off” to produce proteins that carry out specific functions. Identifying a consistent “program” of gene expression associated with neurotransmission suggests that there’s a coordinated set of genes working together to enable this vital process. This isn’t about a single “neurotransmission gene,” but rather a complex interplay of thousands of genes.

Living Brains, Real-Time Insights

Historically, research into brain gene expression has relied heavily on post-mortem tissue. While valuable, this approach has limitations. The act of dying, and the subsequent storage of tissue, can alter gene expression patterns, potentially obscuring the true picture of how genes function in a living, active brain. The Living Brain Project overcomes this hurdle by obtaining samples during neurosurgical procedures, allowing researchers to study gene expression in individuals whose brains are still functioning.

The study involved two main groups of participants. Fifteen individuals performed a cognitive task while undergoing intracranial recordings of the substantia nigra, a brain region involved in reward and movement. A larger group of 115 participants were at rest during recordings of either the subthalamic nucleus or the globus pallidus, areas crucial for motor control. Analyzing data from both groups, and confirming the findings in a third independent cohort, allowed the researchers to identify a “transcriptional program associated with neurotransmission” (TPAWN) – a set of genes consistently linked to neurotransmission across multiple studies.

What Does TPAWN Tell Us?

The identification of TPAWN is significant because it provides a foundation for further investigation into the molecular basis of brain disorders. The researchers found that the genes within TPAWN have validated roles in neurotransmission and overall brain function, as evidenced by studies in model systems and analyses of genetic variation in human populations. As reported by Medical Xpress, this discovery offers unprecedented insight into these mechanisms.

However, it’s crucial to note the limitations of the study. The initial analysis of the group of 15 participants performing a cognitive task was underpowered, meaning the sample size was relatively slight, which limited the ability to identify individual gene-trait associations with high confidence. Despite this, the researchers were able to detect transcriptome-wide signatures of gene expression associated with neurotransmission traits, and these signatures were successfully replicated in larger datasets. This replication strengthens the validity of the findings, but doesn’t eliminate the possibility of other factors influencing the observed associations.

Beyond Correlation: Understanding Causation

The study demonstrates a correlation between the TPAWN genes and neurotransmission traits, but it doesn’t prove causation. In other words, it shows that these genes are associated with neurotransmission, but it doesn’t necessarily mean that changes in these genes directly cause changes in neurotransmission. Further research is needed to establish causal relationships and to understand the precise mechanisms by which these genes influence brain function.

Implications for Psychiatric Disorders

Disruptions in neurotransmission are implicated in a wide range of psychiatric disorders, including depression, schizophrenia, and Parkinson’s disease. By identifying the genes involved in normal neurotransmission, this research opens up new avenues for understanding the molecular basis of these disorders. It may be possible to identify individuals at risk for developing these conditions based on their gene expression profiles, or to develop new therapies that target specific genes within the TPAWN to restore normal neurotransmission.

It’s crucial to emphasize that this research is still in its early stages. The identification of TPAWN is a foundational step, but much work remains to be done before these findings can be translated into clinical applications.

The Path Forward: Validation and Therapeutic Targets

The next steps in this research will likely involve further validation of the TPAWN genes in larger and more diverse populations. Researchers will also need to investigate the functional roles of these genes in more detail, using a variety of techniques, including gene editing and animal models. Mount Sinai’s newsroom highlights the potential for this research to inform the development of new treatments for neurological and psychiatric conditions.

a deeper understanding of the genetic basis of neurotransmission could lead to more effective and personalized treatments for a wide range of brain disorders. The Living Brain Project and studies like this one are paving the way for a new era of precision medicine in neuroscience, where treatments are tailored to the individual genetic makeup of each patient.